CN112680408A - Culture medium for inducing human mesenchymal stem cells to form cartilage differentiation and preparation method thereof - Google Patents

Culture medium for inducing human mesenchymal stem cells to form cartilage differentiation and preparation method thereof Download PDF

Info

Publication number
CN112680408A
CN112680408A CN201911010808.7A CN201911010808A CN112680408A CN 112680408 A CN112680408 A CN 112680408A CN 201911010808 A CN201911010808 A CN 201911010808A CN 112680408 A CN112680408 A CN 112680408A
Authority
CN
China
Prior art keywords
mesenchymal stem
stem cells
differentiation
medium
human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201911010808.7A
Other languages
Chinese (zh)
Inventor
李艳群
李治寰
刘冬羽
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dongguan Xuanguan stem cell regenerative medicine Co.,Ltd.
Original Assignee
Dongguan Enlian Stem Cell Biotechnology Research Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dongguan Enlian Stem Cell Biotechnology Research Institute filed Critical Dongguan Enlian Stem Cell Biotechnology Research Institute
Priority to CN201911010808.7A priority Critical patent/CN112680408A/en
Publication of CN112680408A publication Critical patent/CN112680408A/en
Pending legal-status Critical Current

Links

Images

Abstract

The invention provides a culture medium capable of inducing human mesenchymal stem cells to be chondrogenic differentiation, and belongs to the technical field of stem cell culture. The chondrogenic induction culture medium comprises the following components: low-sugar DMEM basal medium, fetal bovine serum, sodium pyruvate, ascorbic acid, proline, dexamethasone, transferrin, insulin, sodium selenite and transforming growth factor beta 3 (TGF-beta 3). The culture medium is used for inducing the mesenchymal stem cells to have higher chondrogenic differentiation success rate under a two-dimensional culture environment, and the differentiation time only needs 19 days.

Description

Culture medium for inducing human mesenchymal stem cells to form cartilage differentiation and preparation method thereof
Technical Field
The invention relates to an induction culture medium for directional differentiation of human mesenchymal stem cells into cartilage.
Background
Mesenchymal stem cells are a class of cells that are self-replicating and have multi-differentiation potential. In the human body, mesenchymal stem cells are present in various tissues such as umbilical cord, fat, bone marrow, dental pulp, placenta, and the like, and can be isolated and expanded in vitro for many generations. Under the culture of a differentiation culture medium, the mesenchymal stem cells can be differentiated into various tissue cells such as fat, bone, cartilage, muscle, nerve, skin and the like. Therefore, mesenchymal stem cells have been widely used in clinical studies on functional damage repair of tissues and organs. For example, in a plurality of early clinical researches, researchers use adipose-derived mesenchymal stem cells to repair cartilage tissues, so that good curative effects are obtained, and the mesenchymal stem cells are shown to have great clinical transformation potential.
At present, the mesenchymal stem cell chondrogenesis induction culture medium usually adopts DMEM/F12 high-sugar culture medium as a basic culture medium. The chondroblasts obtained by the technology have limited differentiation efficiency, the differentiation time is as long as 28 days, the number of induced chondroblasts is small, the survival rate is low, and the requirements of research and clinical cartilage repair cannot be well met. In order to obtain sufficient chondrocytes differentiated from the mesenchymal stem cells to better meet clinical requirements, mesenchymal stem cell differentiation culture conditions need to be optimized, sufficient chondrocytes are obtained in a shorter time, and favorable conditions are provided for clinical application of the mesenchymal stem cells for cartilage injury treatment, cosmetology or biological activity identification of the mesenchymal stem cells.
Disclosure of Invention
In order to solve the problems of the prior art that the chondrogenesis induction efficiency and specificity are not ideal enough, the induction time is long and the like, the invention provides a culture medium capable of inducing mesenchymal stem cells to chondrogenesis differentiation within 19 days and a preparation method thereof.
A culture medium for inducing chondrogenic differentiation of human mesenchymal stem cells, comprising: the composition comprises low-sugar DMEM medium (LG-DMEM), Fetal Bovine Serum (FBS) 5-50% by volume, sodium pyruvate 50-100 μ g/ml, ascorbic acid 20-200 μ g/ml, proline 10-120ng/ml, dexamethasone 39-500ng/ml, insulin-transferrin-solarization additive (ITS) 0.5-1% by volume, and transforming growth factor-beta 3 (TGF-beta 3)0.1-20 ng/ml.
Preferably, the composition is prepared from the following components: LG-DMEM medium, FBS 10% volume percentage, sodium pyruvate 100 mug/ml concentration, ascorbic acid 50 mug/ml concentration, proline 40 mug/ml concentration, dexamethasone 39ng/ml, ITS 1% volume percentage, TGF-beta 310 ng/ml concentration.
A preferred ITS comprises 1.0mg/ml human recombinant insulin, 0.55mg/ml human transferrin and 0.5. mu.g/ml 100 Xconcentration of sodium selenite.
Preferred basal media contain one or more inorganic salts, vitamins, amino acids, antibiotics, and the like.
Preferably, the human mesenchymal stem cells are umbilical cord mesenchymal stem cells and adipose mesenchymal stem cells from the second generation to the fifth generation.
A preparation method of a culture medium for inducing differentiation of human mesenchymal stem cells into cartilage comprises the following steps:
1) sterilizing a culture bottle: washing the culture bottle, washing with deionized water, air drying, wrapping with paper or cloth, or placing in a metal box, sterilizing at 121 deg.C for 30min, and drying;
2) DMEM medium addition: adding LG-DMEM medium into a culture bottle under aseptic conditions;
3) mixing the components: adding the FBS, the sodium pyruvate mother liquor, the ascorbic acid mother liquor, the proline mother liquor, the dexamethasone mother liquor, the ITS mother liquor and the TGF-beta 3 mother liquor with the concentration, and uniformly mixing;
4) and (3) filtering and sterilizing: the mixed medium was sterilized by filtration through a 0.22 μm filter.
The human mesenchymal stem cell chondrogenic induction differentiation is carried out by the following method:
1) obtaining the stem cells: culturing and amplifying the human mesenchymal stem cells by using LG-DMEM medium containing 10% FBS;
2) pretreatment: digesting the cells with pancreatin, resuspending the cells in LG-DMEM medium containing 10% FBS;
3) cell inoculation: 5 μ L of the extract containing 5X 105Dropping the cell suspension of each cell on a twenty-four pore plate, wherein one pore is one drop;
4) differentiation culture: the cells were placed in an incubator for 2 hours, and 1ml of the human mesenchymal stem cells were added to each well, and cultured in a chondrogenic differentiation induction medium for 19 days.
Drawings
FIG. 1 is a staining chart of Alisin blue of a chondrocyte pellet section formed 19 days after chondrogenic induction of human umbilical cord mesenchymal stem cells
FIG. 2 is a staining diagram of Alisin blue of cartilage globules formed 19 days after the human adipose-derived mesenchymal stem cells are induced into cartilage
Detailed Description
The following will further describe the present invention with reference to specific embodiments.
Example 1: chondrogenic differentiation of human umbilical cord mesenchymal stem cells
The patent provides a preparation of chondrogenic induction culture medium:
1) the human umbilical cord mesenchymal stem cells of the generation P2 are arranged according to the proportion of 1 x 105The density of the cells seeded was 5. mu.l in the center of a 24-well plate and cultured for 2 hours.
2) Cartilage induction medium was prepared according to the composition and amounts shown in table 1:
TABLE 1 chondrogenic differentiation-inducing medium
Component (A) Dosage of
LG-DMEM 50ml
FBS 10%
TGF-β3 10ng/ml
ITS 1%
Dexamethasone 39ng/ml
Ascorbic acid 50μg/ml
Pyruvic acid sodium salt 100μg/ml
Proline 40μg/ml
3) After 2 hours, 1ml of chondrogenic differentiation induction medium prepared according to the method in Table 1 was added, and then the fresh chondrogenic differentiation induction medium was replaced every two days, and chondrocytes were obtained after induction for 19 days.
4) The differentiation degree of chondrogenic tissue was identified by using aliskiren staining solution, and the results are shown in fig. 1.
Example 2: chondrogenic differentiation of human adipose-derived mesenchymal stem cells
1) The human adipose-derived mesenchymal stem cells of generation P2 are arranged according to the ratio of 1 × 105The density of the cells seeded was 5. mu.l in the center of a 24-well plate and cultured for 2 hours.
2) Cartilage induction medium was prepared according to the composition and amounts shown in table 2:
TABLE 2 chondrogenic differentiation induction medium
Component (A) Dosage of
LG-DMEM 50ml
FBS 10%
TGF-β3 10ng/ml
ITS 1%
Dexamethasone 39ng/ml
Ascorbic acid 50μg/ml
Pyruvic acid sodium salt 100μg/ml
Proline 40μg/ml
3) After 2 hours, 1ml of chondrogenic differentiation induction medium prepared according to the method in table 2 was added, and then the fresh chondrogenic differentiation induction medium was replaced every two days, and chondrocytes were obtained after induction for 19 days.
4) The differentiation degree of chondrogenic tissue was identified by using aliskiren staining solution, and the results are shown in fig. 2.

Claims (8)

1. A medium for inducing chondrogenic differentiation of mesenchymal stem cells, comprising: is prepared from the following components, including low sugar DMEM culture medium, Fetal Bovine Serum (FBS) 5-50% volume percentage, sodium pyruvate 50-100 mug/ml concentration, ascorbic acid 20-200 mug/ml concentration, proline 10-120ng/ml concentration, dexamethasone 39-500ng/ml concentration, insulin-transferrin-solarization additive (ITS) 0.5-1% volume percentage, TGF-beta 30.1-20 ng/ml concentration.
2. The human mesenchymal stem cell chondrogenic induction differentiation medium according to claim 1, characterized by being prepared from a low sugar DMEM medium, FBS 10% by volume, sodium pyruvate at a concentration of 100 μ g/ml, ascorbic acid at a concentration of 50 μ g/ml, proline at a concentration of 40ng/ml, dexamethasone at 39ng/ml, ITS 1% by volume, TGF- β 310 ng/ml.
3. The method for preparing a culture medium for inducing differentiation of human mesenchymal stem cells into cartilage according to claim 1, comprising the steps of,
1) sterilizing the culture bottle, washing the culture bottle with deionized water, air drying, wrapping with paper or cloth, or placing in a metal box, sterilizing at 121 deg.C for 30min, and oven drying;
2) adding a DMEM medium, and adding the low-sugar DMEM medium into a culture bottle under an aseptic condition;
3) mixing the components, adding the FBS, the sodium pyruvate mother liquor, the ascorbic acid mother liquor, the proline mother liquor, the dexamethasone mother liquor, the ITS mother liquor and the TGF-beta 3 mother liquor with the concentration, and uniformly mixing;
4) the mixed culture medium was sterilized by filtration through a 0.22 μm filter.
4. The method for preparing the culture medium for inducing differentiation of human mesenchymal stem cells into cartilage according to claim 1, wherein the differentiation of human mesenchymal stem cells into cartilage is induced by the following method,
1) obtaining the stem cells: culturing and amplifying the human mesenchymal stem cells by using a low-sugar DMEM medium containing 10% FBS;
2) pretreatment: digesting the cells with pancreatin, centrifuging at 1200rpm to obtain cell pellets, and suspending the cells in low-sugar DMEM medium containing 10% FBS;
3) cell inoculation: 5 μ L of the extract containing 5X 105Dropping the cell suspension of each cell on a twenty-four pore plate, one drop and one pore;
4) differentiation culture: the cells are placed in an incubator for 2 hours, 1ml of the human mesenchymal stem cell culture medium is added into each hole, and chondrogenic differentiation induction culture medium culture is carried out for 19 days.
5. The medium for inducing the differentiation of mesenchymal stem cells into cartilage according to claim 1, wherein the human mesenchymal stem cells are derived from umbilical cord mesenchymal stem cells and adipose mesenchymal stem cells.
6. The method of claim 5, wherein the umbilical cord mesenchymal stem cells are umbilical cord mesenchymal stem cells and adipose mesenchymal stem cells for second to fifth generations.
7. The medium for inducing differentiation of mesenchymal stem cells into cartilage according to claim 1, wherein the ITS is a mixture of human recombinant insulin, human transferrin and sodium selenite, and comprises 1.0mg/ml human recombinant insulin, 0.55mg/ml human transferrin and 0.5 μ g/ml 100 Xconcentration of sodium selenite.
8. The method of chondrogenic induced differentiation of human mesenchymal stem cells according to claim 4, wherein the mesenchymal stem cells are cultured in an environment having a carbon dioxide content of 5% and 37 ℃.
CN201911010808.7A 2019-10-18 2019-10-18 Culture medium for inducing human mesenchymal stem cells to form cartilage differentiation and preparation method thereof Pending CN112680408A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201911010808.7A CN112680408A (en) 2019-10-18 2019-10-18 Culture medium for inducing human mesenchymal stem cells to form cartilage differentiation and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201911010808.7A CN112680408A (en) 2019-10-18 2019-10-18 Culture medium for inducing human mesenchymal stem cells to form cartilage differentiation and preparation method thereof

Publications (1)

Publication Number Publication Date
CN112680408A true CN112680408A (en) 2021-04-20

Family

ID=75445232

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201911010808.7A Pending CN112680408A (en) 2019-10-18 2019-10-18 Culture medium for inducing human mesenchymal stem cells to form cartilage differentiation and preparation method thereof

Country Status (1)

Country Link
CN (1) CN112680408A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111826343A (en) * 2020-07-23 2020-10-27 北京中卫医正科技有限公司 Cell culture solution for enhancing induced cartilage differentiation, method and application
CN115369078A (en) * 2022-08-19 2022-11-22 创芯国际生物科技(广州)有限公司 Cartilage organoid induction culture medium and induction method

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102174468A (en) * 2011-02-24 2011-09-07 暨南大学 Method and application for inducing human umbilical cord mesenchyme stem cells to be differentiated into testicular interstitial cells
CN108531448A (en) * 2018-03-06 2018-09-14 安徽瑞杰赛尔生物科技有限公司 A kind of human mesenchymal stem cell is at chondrocyte induction differential medium and preparation method

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102174468A (en) * 2011-02-24 2011-09-07 暨南大学 Method and application for inducing human umbilical cord mesenchyme stem cells to be differentiated into testicular interstitial cells
CN108531448A (en) * 2018-03-06 2018-09-14 安徽瑞杰赛尔生物科技有限公司 A kind of human mesenchymal stem cell is at chondrocyte induction differential medium and preparation method

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
应涌泉等: "慢性缺氧对人类骨髓间充质干细胞影响的实验研究", 《中国分子心脏病学杂志》 *
王彦强等: "人脐带间充质干细胞成软骨诱导过程中软骨标志基因表达的研究", 《中华临床医师杂志(电子版)》 *
陆士新: "《干细胞与肿瘤》", 31 July 2009, 中国协和医科大学出版社 *
黄绍代等: "PKH26荧光素标记脂肪间充质干细胞的生物学特性的研究", 《安徽医科大学学报》 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111826343A (en) * 2020-07-23 2020-10-27 北京中卫医正科技有限公司 Cell culture solution for enhancing induced cartilage differentiation, method and application
CN115369078A (en) * 2022-08-19 2022-11-22 创芯国际生物科技(广州)有限公司 Cartilage organoid induction culture medium and induction method

Similar Documents

Publication Publication Date Title
CN112322580B (en) Application of serum-free medium for mesenchymal stem cells
KR100908481B1 (en) Mesenchymal stem cell culture medium and culture method of mesenchymal stem cells using the same
CN106754668B (en) Stem cell culture solution and injection
CN107418928B (en) Osteogenic induction differentiation culture medium for human mesenchymal stem cells and preparation method thereof
CN102985534A (en) Culture method for amplifying large numbers of hair follicle stem cells in vitro
CN108531448A (en) A kind of human mesenchymal stem cell is at chondrocyte induction differential medium and preparation method
CN104726406A (en) Method for inducing dental pulp mesenchymal stem cells to be differentiated into nerve cells
CN110938590B (en) Mesenchymal stem cell serum-free medium and application thereof
CN113564111B (en) Method for culturing umbilical cord-derived mesenchymal stem cells in low-oxygen mode
US20050059152A1 (en) In vitro culture of mesenchymal stem cells (MSC) and a process for the preparation thereof for therapeutic use
CN112592890A (en) Method for promoting proliferation of muscle stem cells
CN112608894A (en) Mesenchymal stem cell culture medium
CN112553148A (en) Improved culture medium for in vitro amplification culture of meat seed cells and application of improved culture medium
CN103223194A (en) Cartilage graft for cartilage injury repair and preparation method thereof
CN112680408A (en) Culture medium for inducing human mesenchymal stem cells to form cartilage differentiation and preparation method thereof
CN113692282A (en) Bioactive substance composition, serum-free culture medium containing composition and application of serum-free culture medium
CN114480273A (en) Culture medium for obtaining mesenchymal stem cells and exosomes thereof and preparation method thereof
CN111235101B (en) Culture medium and culture method for human umbilical cord mesenchymal stem cells
CN113151165B (en) Culture medium and culture method for human umbilical cord mesenchymal stem cell amplification
CN112195151B (en) Dental pulp mesenchymal stem cell recovery culture solution, preparation method and recovery culture method
JP2011211956A (en) Undifferentiation-maintaining agent for stem cell and growth-promoting agent
CN113943702A (en) Culture medium for amplifying amniotic mesenchymal stem cells and preparation method thereof
CN112708598A (en) Neural precursor cell culture medium without serum component and preparation method and application thereof
CN112458049A (en) Low-cost method for in vitro culture of pork muscle stem cells
CN110592008A (en) Method for culturing bone marrow mesenchymal stem cells of canine animals

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
TA01 Transfer of patent application right
TA01 Transfer of patent application right

Effective date of registration: 20210806

Address after: Room 407, building 3, No. 430, Nancheng section, Dongguan Avenue, Nancheng street, Dongguan City, Guangdong Province, 523000

Applicant after: Dongguan Xuanguan stem cell regenerative medicine Co.,Ltd.

Address before: 523000 Huihai Building Shop 409-411, 430 Dongguan Avenue, Yuanwubian Community, Nancheng Street, Dongguan City, Guangdong Province

Applicant before: Dongguan Enlian Stem Cell Biotechnology Research Institute